CD8A and cancer: Adoptive immunotherapy, or the infusion of ex vivo activated and expanded tumor-specific CD8+ T cells into cancer patients, is a strategy involving removal of CD8+ T cells from the tumor environment and provision of stimulatory conditions necessary for their optimal activation, in attempts to overcome poor T-cell responsiveness to tumors.